SUPN
#1776
Supernus Pharmaceuticals, Inc. - Common Stock
47.3 5 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.29%
Variación mensual
+6.74%
Variación en los últimos 6 meses
-7.60%
Cambio anual
-12.31%
Cierres anteriores
48.4 6
Open
47.3 5
Mínimo
47.3 5
High
47.3 5
Volumen
66
Financials
- Market Capitalization 2.75 B
- Employee 778
- Founded 2005
- CEO Jack A. Khattar
- Website www.supernus.com
- Headquarter Delaware, United States
- FIGI BBG000BP0HX7
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-73.09
Relación precio/flujo de caja
3.9
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1275 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.18 USD | +1.00% | +0.29% | +6.58% | +62.84% | 5.48 B USD | ||
| 1358 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 40.21 USD | -0.72% | +0.47% | +3.93% | +19.67% | 4.90 B USD | ||
| 1848 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.05 USD | -14.12% | -8.35% | -73.18% | -64.39% | 2.50 B USD | ||
| 1897 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 48.89 USD | -0.14% | +0.60% | +3.01% | -36.05% | 2.32 B USD |